Immunologists hand-labeled individual cells, stalling discovery. GenAI now automates annotation, cutting research timelines by 50%.
A biotech analytics firm helps pharmaceutical companies interpret massive single-cell RNA sequencing (scRNA-seq) datasets required for developing precision medicine therapies.
Identifying cell clusters in genetic data was a manual bottleneck requiring specialized immunologists to label individual cells by hand. This...
“We needed to find a way to empower researchers to gain insights faster without being bogged down by the labor-intensive process of data annotation. Our goal was to help them focus on discovery and innovation rather than manual data annotation.”
Data analytics and bioinformatics platform for precision medicine and drug discovery.
Cloud computing platform and on-demand infrastructure services.
Related implementations across industries and use cases
Manual analysis of vast biomedical data slowed research. An automated AI pipeline now accelerates interpretation, halving study timelines.
Researchers spent months scouring medical literature. GenAI now mines insights in minutes, accelerating cancer test development.
Predicting a single protein binding took 2,000 hours. Deep learning models now complete the task in just 15 minutes.
Silos forced teams to manually chase data. Now, AI agents identify adverse events in seconds, eliminating weeks of cross-referencing.
Attorneys juggled fragmented tools to search 50,000 cases. An AI orchestrator now routes queries to sub-agents in a single chat.
Lab supply orders were handwritten in notebooks. Digital ordering now takes seconds, saving 30,000 hours for research annually.
Experts spent 15 minutes pulling data from scattered systems. Natural language prompts now generate detailed reports instantly.